ciprofloxacin and azlocillin

ciprofloxacin has been researched along with azlocillin in 43 studies

Research

Studies (43)

Timeframe	Studies, this research(%)	All Research%
pre-1990	26 (60.47)	18.7374
1990's	11 (25.58)	18.2507
2000's	4 (9.30)	29.6817
2010's	2 (4.65)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kwon, DH; Lu, CD	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barrow, K; Kwon, DH	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Anderson, KC; Kellogg, GE; Sarkar, A	1
Bingen, E; Denamur, E; Elion, J; Foucaud, P; Goullet, P; Lambert-Zechovsky, N; Navarro, J; Picard, B	1
Johnson, PR; Liu Yin, JA; Tooth, JA	1
Hyatt, DS; McCarthy, DM; Rogers, TR; Samson, DS	1
Cellini, L; D'Antonio, D; Di Girolamo, A; Fioritoni, G; Iacone, A; Nicoletti, M; Piccolomini, R	1
Blaser, J; Dudley, MN; Gilbert, D; Mayer, KH; Zinner, SH	1
Bustamante, CI; Wade, JC; Wharton, RC	1
Witte, W; Wolter, EJ	1
Barker, KF; Kaczmarski, RS; Mufti, GJ; Philpott-Howard, JN; Smedley, JC; Wade, JJ	1
Barriere, SL; Catlin, DH; Frost, RW; Noe, A; Orlando, PL	1
Arnow, P; Edlin, B; Flaherty, JP; George, D; O'Keefe, P; Waitley, D; Weinstein, RA	1
Batten, JC; Butland, RJ; Hodson, ME; Roberts, CM; Smith, MJ	1
Gratz, JC; Maserati, R; Scheld, WM; Strunk, RW	1
Gerding, DN; Moody, JA; Peterson, LR	1
Chin, NX; Jules, K; Neu, HC	1
Chalkley, LJ; Koornhof, HJ	1
Alkan, M; Berger, S; Mark, Z; Rubinstein, E; Samra, Y	1
Grohe, K; Metzger, KG; Schacht, P; Zeiler, HJ	1
Bindschedler, M; Follath, F; Frei, R; Reber, H; Stalder, H; Wenk, M	1
Bayer, AS; Blomquist, IK; Kim, KS	1
Bayer, AS; Kim, KS	1
Bamberger, DM; Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR	1
Rubio, TT; Shapiro, C	1
Dudley, MN; Zinner, SH	1
Andriole, VT; Johnson, M; Miniter, P	1
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR	1
Heilmann, F; Heizmann, W; Werner, H	1
Marks, MI; Parker, KM; Stutman, HR	1
Overbeek, BP; Rozenberg-Arska, M; Verhoef, J	1
Mellinghoff, D; Shah, PM; Stille, W	1
Bosso, JA; Walker, KB	1
Fasching, CE; Gerding, DN; Peterson, LR	1
Black, PG; Bosso, JA; Matsen, JM	1
Rubio, TT	1
Davidson, S; Nakatomi, M; Neu, HC; Ores, C; Scully, BE	1
Hows, J; Körner, RJ; MacGowan, AP; Nicol, A; Reeves, DS	1
Po, AL; Scott, EM; Tariq, VN; Wu, YL	1
Engelhardt, D; Ruckdeschel, G	1

Trials

9 trial(s) available for ciprofloxacin and azlocillin

Article	Year
A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients. The Journal of antimicrobial chemotherapy, 1992, Volume: 30, Issue:2 Topics: Adolescent; Adult; Aged; Azlocillin; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Netilmicin; Neutropenia	1992
A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients. The Journal of antimicrobial chemotherapy, 1991, Volume: 28, Issue:2 Topics: Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Netilmicin; Neutropenia; Prospective Studies	1991
Clinical efficacy and in vitro activity of the ciprofloxacin-azlocillin combination (ratio 1:10) against gram-negative bacteria from non-neutropenic haematologic patients. Drugs under experimental and clinical research, 1991, Volume: 17, Issue:9 Topics: Adult; Aged; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Diseases; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Opportunistic Infections; Prospective Studies	1991
Randomized multicentre study of ciprofloxacin and azlocillin versus gentamicin and azlocillin in the treatment of febrile neutropenic patients. The Journal of antimicrobial chemotherapy, 1990, Volume: 26 Suppl F Topics: Adolescent; Adult; Azlocillin; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Neutropenia; Remission Induction; Superinfection	1990
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients. The American journal of medicine, 1989, Nov-30, Volume: 87, Issue:5A Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Random Allocation	1989
Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis. Lancet (London, England), 1987, Jan-31, Volume: 1, Issue:8527 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Azlocillin; Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Drug Therapy, Combination; Female; Gentamicins; Humans; Injections, Intravenous; Male; Pseudomonas Infections; Random Allocation; Respiratory Function Tests	1987
Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis. The American journal of medicine, 1987, Apr-27, Volume: 82, Issue:4A Topics: Adult; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Drug Therapy, Combination; Humans; Lung Diseases; Random Allocation; Therapeutic Equivalency; Tobramycin	1987
Ciprofloxacin: comparative data in cystic fibrosis. The American journal of medicine, 1987, Apr-27, Volume: 82, Issue:4A Topics: Adolescent; Adult; Azlocillin; Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Penicillin Resistance; Pseudomonas Infections; Tobramycin	1987
Ciprofloxacin therapy in cystic fibrosis. The American journal of medicine, 1987, Apr-27, Volume: 82, Issue:4A Topics: Adolescent; Adult; Azlocillin; Child; Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Pseudomonas Infections; Tobramycin	1987

Other Studies

34 other study(ies) available for ciprofloxacin and azlocillin

Article	Year
Polyamine effects on antibiotic susceptibility in bacteria. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Anti-Bacterial Agents; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Transcription Factors	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics. European journal of medicinal chemistry, 2012, Volume: 52 Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics	2012
Molecular epidemiological analysis of Pseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1992, Volume: 11, Issue:5 Topics: Azlocillin; Bacterial Typing Techniques; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Drug Therapy, Combination; Esterases; Humans; Imipenem; Polymorphism, Restriction Fragment Length; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections	1992
Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas aeruginosa: effect of simultaneous versus staggered administration in an in vitro model of infection. The Journal of infectious diseases, 1991, Volume: 164, Issue:3 Topics: Azlocillin; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Models, Biological; Pseudomonas aeruginosa; Time Factors	1991
In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:9 Topics: Azlocillin; Aztreonam; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Microbial Sensitivity Tests; Pseudomonas aeruginosa	1990
Instability of in vitro resistance to imipenem in Pseudomonas aeruginosa. Journal of basic microbiology, 1990, Volume: 30, Issue:8 Topics: Azlocillin; Aztreonam; Bacterial Outer Membrane Proteins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Imipenem; Pseudomonas aeruginosa	1990
Alteration in the pharmacokinetic disposition of ciprofloxacin by simultaneous administration of azlocillin. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:5 Topics: Adult; Azlocillin; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Interactions; Half-Life; Humans; Male; Mezlocillin	1990
Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis. Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:3 Topics: Animals; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Tobramycin	1985
In vitro activity of ciprofloxacin combined with azlocillin. Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:6 Topics: Anti-Bacterial Agents; Azlocillin; Bacteria, Aerobic; Ciprofloxacin; Drug Interactions; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolines	1985
Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection. European journal of clinical microbiology, 1986, Volume: 5, Issue:1 Topics: Animals; Azlocillin; Bacteria; Carbenicillin; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Gentamicins; Humans; Listeria monocytogenes; Male; Mice; Neisseriaceae; Neutropenia; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Staphylococcus aureus; Streptococcus; Ticarcillin	1986
Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions. Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:2 Topics: Azlocillin; Aztreonam; Ciprofloxacin; Drug Synergism; Escherichia coli; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Tobramycin	1985
In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:2 Topics: Acinetobacter; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Azlocillin; Bacteria; Cefamandole; Cefotaxime; Cefsulodin; Ciprofloxacin; Citrobacter; Cloxacillin; Enterobacter; Escherichia coli; Gentamicins; Humans; Klebsiella pneumoniae; Mezlocillin; Penicillin Resistance; Proteus; Pseudomonas aeruginosa; Quinolines; Serratia marcescens; Shigella; Staphylococcus	1986
Assessment of the in vitro and in vivo activity of ciprofloxacin measured against current standards of therapy. Drugs under experimental and clinical research, 1985, Volume: 11, Issue:5 Topics: Ampicillin; Animals; Azlocillin; Blood; Ciprofloxacin; Escherichia coli; Humans; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Sisomicin; Tobramycin	1985
Use of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections. European journal of clinical microbiology, 1986, Volume: 5, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Ciprofloxacin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Immune Tolerance; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines	1986
Ciprofloxacin in experimental aortic valve endocarditis due to Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 1986, Volume: 17, Issue:5 Topics: Abscess; Animals; Anti-Infective Agents; Aortic Valve; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Kidney Diseases; Microbial Sensitivity Tests; Netilmicin; Penicillin Resistance; Pseudomonas Infections; Quinolines; Rabbits	1986
In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa. Chemotherapy, 1986, Volume: 32, Issue:4 Topics: Amikacin; Animals; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Kanamycin; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Time Factors	1986
Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model. The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:1 Topics: Amikacin; Animals; Azlocillin; Cefotaxime; Ceftizoxime; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gram-Negative Bacteria; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rabbits	1986
Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients. The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl D Topics: Adolescent; Adult; Azlocillin; Ciprofloxacin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tobramycin	1986
Bactericidal activity of ciprofloxacin alone and in combination with azlocillin in an in-vitro capillary model. The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl D Topics: Azlocillin; Ciprofloxacin; Drug Combinations; Escherichia coli; Kinetics; Klebsiella pneumoniae; Models, Biological; Pseudomonas aeruginosa	1986
Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis. The Journal of infectious diseases, 1987, Volume: 155, Issue:4 Topics: Animals; Azlocillin; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Female; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Strains; Tobramycin	1987
In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model. Diagnostic microbiology and infectious disease, 1987, Volume: 7, Issue:2 Topics: Amikacin; Animals; Azlocillin; Ciprofloxacin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Kinetics; Neutropenia; Penicillin G; Rabbits; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae	1987
Evaluation of the Cobas Bact automated system for susceptibility testing of Enterobacteriaceae, Pseudomonas aeruginosa, and Enterococcus faecalis to azlocillin, mezlocillin, and ciprofloxacin compared to NCCLS and DIN standards. Infection, 1988, Volume: 16, Issue:1 Topics: Autoanalysis; Azlocillin; Ciprofloxacin; Enterobacteriaceae; Mezlocillin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Software	1988
Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates. Pediatrics, 1985, Volume: 75, Issue:2 Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Bilirubin; Binding Sites; Cefoperazone; Ciprofloxacin; Enoxacin; Humans; Imipenem; In Vitro Techniques; Infant, Newborn; Moxalactam; Naphthyridines; Quinolines; Serum Albumin; Thienamycins	1985
Interaction between ciprofloxacin and tobramycin or azlocillin against multiresistant strains of Acinetobacter anitratum in vitro. European journal of clinical microbiology, 1985, Volume: 4, Issue:2 Topics: Acinetobacter; Azlocillin; Ciprofloxacin; Drug Synergism; Microbial Sensitivity Tests; Quinolines; Tobramycin	1985
[Ciprofloxacin in combination with other antimicrobial substances]. Arzneimittel-Forschung, 1988, Volume: 38, Issue:3 Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Ciprofloxacin; Drug Interactions; Imipenem; Mezlocillin; Microbial Sensitivity Tests; Thienamycins; Tobramycin	1988
Lack of correlation between objective indicators and clinical-response scores during antimicrobial therapy for acute pulmonary exacerbations of cystic fibrosis. Clinical pharmacy, 1988, Volume: 7, Issue:12 Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Ciprofloxacin; Cystic Fibrosis; Humans; Tobramycin	1988
Treatment of ciprofloxacin- and ceftizoxime-induced resistant gram-negative bacilli. The American journal of medicine, 1987, Apr-27, Volume: 82, Issue:4A Topics: Amikacin; Animals; Azlocillin; Bacterial Infections; Cefotaxime; Ceftizoxime; Ciprofloxacin; Drug Evaluation, Preclinical; Female; Gram-Negative Bacteria; Penicillin Resistance; Rabbits	1987
Ciprofloxacin resistant Serratia marcescens endocarditis as a complication of non-Hodgkin's lymphoma. The Journal of infection, 1994, Volume: 29, Issue:1 Topics: Azlocillin; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Gentamicins; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Middle Aged; Serratia Infections; Serratia marcescens	1994
Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1999, Volume: 107, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azlocillin; Ceftazidime; Cephalosporins; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	1999
Effect of combination therapy with ciprofloxacin and azlocillin in intensive care patients with pneumonia and/or sepsis. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Ciprofloxacin; Clinical Trials as Topic; Critical Care; Drug Therapy, Combination; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pneumonia, Bacterial; Sepsis	1989